Published works

Category

New Publications

NEW
  • Acute Kidney Injury (AKI)
259
Clinical Utility of Liver-type Fatty Acid-binding Protein (L-fabp), and Tissue Inhibitor of Metalloproteinase-2 and Insulin-like Growth Factor-binding Protein-7 (Timp-2*igfbp-7) as Early Detector for Acute Kidney Injury in Surgical Patients After Cardiopulmonary Bypass.
NEW
  • Chronic Kidney Disease (CKD)
  • Pharmacology
258
Different renoprotective effects of luseogliflozin depend on the renal function at the baseline in patients with type 2 diabetes: A retrospective study during 12 months before and after initiation.
PLoS One. 2021
doi: 10.1371/journal.pone.0248577.PubMed
NEW
  • Chronic Kidney Disease (CKD)
  • Pharmacology
257
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial.
Diab Vasc Dis Res. 2018
doi: 10.1177/1479164118782872. Epub 2018 Jun 20.PubMed
NEW
  • Acute Kidney Injury (AKI)
256
Urine Liver-Type Fatty Acid Binding Protein; Biomarker for Diagnosing Acute Kidney Injury and Predicting Mortality in Cirrhotic Patients.
  • Acute Kidney Injury (AKI)
255
A retrospective cohort study evaluating the predictive value of urinary L-FABP combined with the SOFA score for assessing COVID-19 severity.
PLoS One. 2025.
doi: 10.1371/journal.pone.0331558.PubMed
  • Chronic Kidney Disease (CKD)
254
Red blood cell distribution width is associated with renal tubular injury in individuals with type 2 diabetes.
J Diabetes Investig. 2025.
doi: 10.1111/jdi.70149.PubMed
  • Acute Kidney Injury (AKI)
  • Toxicology
253
Interstitial Nephritis Induced by Repeated Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Use for Persistent Fever: A Case Report.
Cureus. 2025.
doi: 10.7759/cureus.87304.PubMed
  • Acute Kidney Injury (AKI)
252
Urinary liver-type fatty acid binding protein as a postoperative marker of acute kidney injury in patients undergoing endovascular aortic aneurysm repair.
J Cardiothorac Vasc Anesth. 2025.
doi: 10.1053/j.jvca.2025.08.020PubMed
  • Chronic Kidney Disease (CKD)
251
Involvement of impaired carnitine-induced fatty acid oxidation in experimental and human diabetic kidney disease.
JCI Insight. 2025.
doi: 10.1172/jci.insight.179362.PubMed
  • Chronic Kidney Disease (CKD)
250
Evaluation of Serum L-FABP as a Biomarker and Hepatoprotective Effect of L-FABP Using Wild-Type and Human L-FABP Chromosome Transgenic Mice.
J Am Assoc Lab Anim Sci. 2025.
doi: 10.30802/AALAS-JAALAS-25-003.PubMed
  • Acute Kidney Injury (AKI)
249
Combination of Urinary Biomarkers for Early Detection of Patients With Acute Kidney Injury After Transcatheter Aortic Valve Implantation.
J Cardiothorac Vasc Anesth. 2025.
doi: 10.1053/j.jvca.2025.06.029.PubMed
  • Acute Kidney Injury (AKI)
  • Toxicology
248
Interstitial Nephritis Induced by Repeated Nonsteroidal Anti-inflammatory Drugs (NSAIDs) Use for Persistent Fever: A Case Report.
Cureus. 2025.
doi: 10.7759/cureus.87304.PubMed
  • Acute Kidney Injury (AKI)
247
Urine and serum L-type fatty acid-binding protein levels in preeclampsia: a prospective cohort study on maternal deterioration predictions.
Hypertens Pregnancy. 2025.
doi: 10.1080/10641955.2025.2534508.PubMed
  • Acute Kidney Injury (AKI)
246
Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.
BMC Nephrol. 2025.
doi: 10.1186/s12882-025-04085-4.PubMed
  • Chronic Kidney Disease (CKD)
245
Urinary L-FABP: A Novel Biomarker for Evaluating Diabetic Nephropathy Onset and Progression. A Narrative Review.
Diabetes Ther. 2025.
doi: 10.1007/s13300-025-01731-w.PubMed
  • Acute Kidney Injury (AKI)
244
Combination of urinary biomarkers can predict cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis.
Ann Intensive Care. 2025.
doi: 10.1186/s13613-025-01459-7.PubMed
  • Acute Kidney Injury (AKI)
  • Toxicology
243
Urinary biomarkers in prediction of subclinical acute kidney injury in pediatric oncology patients treated with nephrotoxic agents.
BMC Nephrol. 2025.
doi: 10.1186/s12882-025-04085-4.PubMed
  • Chronic Kidney Disease (CKD)
242
Development of a multiple urinary biomarker model to predict the tubulointerstitial fibrosis area in patients with primary IgA Nephropathy.
BMC Nephrol. 2025.
doi: 10.1186/s12882-025-04049-8.PubMed
  • Acute Kidney Injury (AKI)
  • Exercise / Heatstroke
241
Liver fatty acid-binding protein point-of-care testing detects heat-induced organ damage: a pilot study in Japanese male self-defense force personnel.
Sci Rep. 2025.
doi: 10.1038/s41598-025-91685-7.PubMed
  • Acute Kidney Injury (AKI)
  • Exercise / Heatstroke
240
The feasibility of point-of-care testing for initial urinary liver fatty acid-binding protein to estimate severity in severe heatstroke.
Sci Rep. 2025.
doi: 10.1038/s41598-025-89767-7.
PubMed
NEWS

2025.12 New articles related to L-FABP were released.

Published works https://fabp.jp/eng/research

2025.10 New articles related to L-FABP were released.

Published works https://fabp.jp/eng/research

2025.8 New articles related to L-FABP were released.

Published works https://fabp.jp/eng/research
TOP